David Toung

Q: What is David Toung's success rate?

David Toung currently has a success rate of 96.46546867887113.

Q: What is the average return of David Toung's calls?

Their stock ratings have generated an average return of 13.35893291007598.

Argus Research | Healthcare

David Toung is an analyst from Argus Research specializing in the Healthcare sector. Ranked #1003 out of 4631 analysts, they have issued 13 stock ratings with a success rate of 96.47% and an average return of 13.36%.

With 13 ratings to date, David Toung is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 96.47% and an average return of 13.36%, highlighting promising potential as their track record develops further.

#1003

Out of 4631

Total Ratings

+96.47%

Success Rate

+13.36%

Average Return

Recent Ratings Analysis

UNH

Buy

Apr 22, 2026

Target

$400.00

Current

$353.52

Performance

0.00%

David Toung rated UNH as Buy on Apr 22, 2026, setting a price target of 400. Shares have remained stable near 353.52, leaving the 400 target still in play.

MDT

Buy

Apr 06, 2026

Target

$115.00

Current

$83.22

Performance

-3.55%

On Apr 06, 2026, MDT was given a Buy rating by David Toung, with a target price of 115. The stock traded sideways with a -3.55% move, keeping the bullish thesis unresolved.

BDX

Buy

Mar 23, 2026

Target

$180.00

Current

$155.65

Performance

-0.37%

BDX received a Buy rating from David Toung on Mar 23, 2026, aiming for 180. Price action was muted, as shares hovered around 155.65 despite the bullish outlook.

PFE

Buy

Mar 02, 2026

Target

$35.00

Current

$26.78

Performance

-1.76%

On Mar 02, 2026, David Toung published a Buy outlook on PFE, with a target of 35. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 26.78.

HCA

Buy

Feb 06, 2026

Target

$560.00

Current

$471.34

Performance

-6.05%

David Toung on Feb 06, 2026 assigned HCA a Buy rating, with a price target of 560. The call has struggled to gain traction, with shares losing 6.05%.

HOLX

Hold

Jan 12, 2026

Target

—

Current

$76.01

Performance

1.54%

On Jan 12, 2026, David Toung reaffirmed HOLX with a Hold rating, targeting null. The neutral call matched muted market action of 1.54%.

TECH

Buy

Nov 20, 2025

Target

$68.00

Current

$58.58

Performance

-0.26%

TECH was rated Buy by David Toung on Nov 20, 2025, with a price objective of 68. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

TMO

Buy

Oct 29, 2025

Target

$610.00

Current

$513.98

Performance

-7.94%

On Oct 29, 2025, David Toung initiated coverage on TMO with a Buy rating and target of 610. The Buy call has yet to be validated as shares remain 96.02 away from the target.

HUM

Hold

Aug 14, 2025

Target

$281.99

Current

$217.40

Performance

-22.73%

David Toung issued a Hold recommendation for HUM on Aug 14, 2025, price target set at 281.99. Market action validated the conservative Hold outlook with shares at 217.4.

ELV

Hold

Jul 21, 2025

Target

—

Current

$328.20

Performance

18.72%

On Jul 21, 2025, ELV was evaluated by David Toung, who gave a Hold rating and target of null. Investors who stayed in despite the Hold saw upside of 18.72%.

GFS

Buy

Jul 01, 2025

Target

$52.00

Current

$60.39

Performance

53.12%

David Toung rated GFS as Buy on Jul 01, 2025, setting a price target of 52. The call has proven timely, with shares rising 53.12% toward the price target of 52.

IART

Buy

Mar 31, 2025

Target

—

Current

$10.75

Performance

-51.11%

On Mar 31, 2025, IART was given a Buy rating by David Toung, with a target price of null. Despite the Buy call, shares fell from 10.75 to 10.75, challenging the optimistic stance.

CAH

Buy

Sep 11, 2024

Target

$125.00

Current

$200.55

Performance

76.93%

CAH received a Buy rating from David Toung on Sep 11, 2024, aiming for 125. Momentum has favored the Buy call, with shares climbing from 200.55 to 200.55, rewarding those who trusted the recommendation.

CRL

Hold

Jun 28, 2024

Target

—

Current

$184.80

Performance

-10.54%

On Jun 28, 2024, David Toung published a Hold outlook on CRL, with a target of null. Weakness in the stock, now at 184.8, supported the conservative rating.

AMGN

Buy

Jun 27, 2024

Target

$340.00

Current

$345.92

Performance

10.27%

David Toung on Jun 27, 2024 assigned AMGN a Buy rating, with a price target of 340. The Buy call aligned well with market performance, producing a gain of 10.27%.

MCK

Buy

Jun 24, 2024

Target

$670.00

Current

$829.23

Performance

36.43%

On Jun 24, 2024, David Toung reaffirmed MCK with a Buy rating, targeting 670. The recommendation was supported by strong follow-through as the stock rose from 829.23 to 829.23.

LLY

Buy

May 14, 2024

Target

$840.00

Current

$921.28

Performance

20.59%

LLY was rated Buy by David Toung on May 14, 2024, with a price objective of 840. A bullish response from the market helped close the gap of -81.28 to the target.

Frequency Asked Questions

Who is David Toung?

David Toung is an analyst from Argus Research specializing in the Healthcare sector.

What is David Toung's success rate?

David Toung currently has a success rate of +96.47%.

How many ratings has David Toung issued?

David Toung has issued 13 stock ratings so far.

What is the average return of David Toung's calls?

Their stock ratings have generated an average return of +13.36%.

What is David Toung's ranking?

David Toung is ranked #1003 out of 4631 analysts.

What types of ratings does David Toung give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow David Toung?

You can follow David Toung by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by David Toung?

Their latest rating was a Buy on UNH issued on 2026-04-22.